ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
-0,05%
Bitcoin
66.065,82
0,09%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. National Research Corporation (NRC)

  7. National Research Corporation (NRC) News

NRC

National Research (NRC)

National Research Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NRC
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202421h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NRCNational Research Corporation
13/05/202421h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NRCNational Research Corporation
10/05/202422h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
10/05/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
10/05/202422h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
10/05/202422h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
10/05/202422h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
09/05/202415h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NRCNational Research Corporation
07/05/202423h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NRCNational Research Corporation
07/05/202423h00Business WireNational Research Corporation Announces First Quarter ResultsNASDAQ:NRCNational Research Corporation
18/04/202422h23Business WireNational Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the InternetNASDAQ:NRCNational Research Corporation
02/04/202417h55Business WireVeteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience OfficerNASDAQ:NRCNational Research Corporation
08/03/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NRCNational Research Corporation
05/03/202422h31Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NRCNational Research Corporation
05/03/202422h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
27/02/202420h44Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NRCNational Research Corporation
13/02/202423h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NRCNational Research Corporation
13/02/202423h00Business WireNational Research Corporation Announces Fourth Quarter and Calendar Year 2023 ResultsNASDAQ:NRCNational Research Corporation
01/02/202421h00Business WireNational Research Corporation to Broadcast Its Fourth Quarter and Year-end 2023 Conference Call Live on the InternetNASDAQ:NRCNational Research Corporation
01/02/202416h00Business WireNRC Health Expands Leadership Team to Accelerate Innovation, Meet Growing Demand for Insights and SolutionsNASDAQ:NRCNational Research Corporation
31/01/202416h00Business WireYuma Regional Medical Center Selects NRC Health as New Patient Experience PartnerNASDAQ:NRCNational Research Corporation
22/01/202422h43Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
22/01/202422h41Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
22/01/202422h38Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
17/01/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NRCNational Research Corporation
17/01/202421h00Business WireNational Research Corporation Elevates Leadership Team to Seize Growth OpportunityNASDAQ:NRCNational Research Corporation
08/01/202423h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
05/01/202422h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
04/01/202423h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
04/01/202423h08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NRCNational Research Corporation
 Showing the most relevant articles for your search:NASDAQ:NRC

Kürzlich von Ihnen besucht

TG
CBK
Commerzbank
TG
BAS
BASF
USOTC
RHHBY
Roche (QX)
DBI
MDAX
MDAX
NYSE
MCD
McDonalds
NASDAQ
AAPL
Apple
TG
432
Arbor Metals
USOTC
DTEGY
Deutsche Telekom (QX)
TG
ALV
Allianz
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
AMEX
XLV
Health Care Select Sector
CCOM
US100
US Tech 100
TG
BAYN
Bayer
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten